Quest Diagnostics (DGX) Inventory (2009 - 2026)

Quest Diagnostics has disclosed Inventory across 18 years of filings, most recently posting $225.0 million for Q1 2026.

• Inventory for Q1 2026 came in at $225.0 million, up 19.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $225.0 million (up 19.05% YoY), and the FY2025 annual result was $189.0 million, up 0.53% from the prior year.
• Inventory came in at $225.0 million for Q1 2026 at Quest Diagnostics, up from $189.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $225.0 million in Q1 2026 to a low of $181.0 million in Q1 2024.
• The 5-year median for Inventory is $187.0 million (2022), against an average of $189.3 million.
• Across the five-year window, Inventory dropped 11.66% in 2022 and advanced 19.05% in 2026, its largest moves.
• Quest Diagnostics' Inventory stood at $192.0 million in 2022, then dropped by 1.04% to $190.0 million in 2023, then fell by 1.05% to $188.0 million in 2024, then gained by 0.53% to $189.0 million in 2025, then rose by 19.05% to $225.0 million in 2026.
• The last three Inventory figures came in at $225.0 million (Q1 2026), $189.0 million (Q4 2025), and $186.0 million (Q3 2025), per Business Quant data.